نتایج جستجو برای: genomic targeted therapy

تعداد نتایج: 883589  

2016
Haa-Na Song Chung Lee Seung Tae Kim Sun Young Kim Nayoung K.D. Kim Jiryeon Jang Mihyun Kang Hyojin Jang Soomin Ahn Seok Hyeong Kim Yoona Park Yong Beom Cho Jeong Wook Heo Woo Yong Lee Joon Oh Park Ho Yeong Lim Won Ki Kang Young Suk Park Woong-Yang Park Jeeyun Lee Hee Cheol Kim

BACKGROUND We aimed to establish a prospectively enrolled colorectal cancer (CRC) cohort for targeted sequencing of primary tumors from CRC patients. In parallel, we established collateral PDC models from the matched primary tumor tissues, which may be later used as preclinical models for genome-directed targeted therapy experiments. RESULTS In all, we identified 27 SNVs in the 6 genes such a...

Journal: :Cancer discovery 2014
Guang Peng Scott E Woodman Gordon B Mills

SUMMARY In this issue of Cancer Discovery, AI-Ahmadie and colleagues identify a somatic mutation in the RAD50 gene as a likely contributing factor to an unusual curative response to systemic combination therapy employing the DNA-damaging agent irinotecan and a checkpoint kinase 1 inhibitor in a patient with recurrent, metastatic small-cell cancer. This study highlights the importance of in-dept...

Journal: :World journal of gastrointestinal oncology 2015
Ozkan Kanat Bert O'Neil Safi Shahda

In the West in particular, the vast majority of gastric cancer (GC) patients present with advanced-stage disease. Although combination chemotherapy is still the most important component of treatment for these patients, it confers a modest survival advantage. Recently, increased knowledge of the key molecular signaling pathways involved in gastric carcinogenesis has led to the discovery of speci...

2013
Marcus W Wiedmann Joachim Mössner

Esophageal cancer comprises two different histological forms - squamous cell carcinoma (SCC) and adenocarcinoma (AC). While the incidence of AC has increased steeply in Western countries during the last few years, the incidence of SCC is fairly stable. Both forms differ in pathogenesis and response to chemotherapy and radiation therapy. Plenty of studies have evaluated new chemotherapy combinat...

Journal: :Oncology research and treatment 2016
Carolin Bender Jessica C Hassel Alexander Enk

Arising from melanocytes in skin, mucosal membranes, eye, and meninges, melanoma is a tumor that has been associated with poor prognosis in advanced disease stages. Given the poor response to chemotherapy and radiation therapy, new treatment approaches with targeted therapy, immunotherapy, and adoptive T-cell therapy have revolutionized the standard of care for patients with advanced melanoma. ...

2015
Evangelos Pazarentzos Trever G. Bivona

The identification of specific genetic alterations that drive the initiation and progression of cancer and the development of targeted drugs that act against these driver alterations has revolutionized the treatment of many human cancers. While substantial progress has been achieved with the use of such targeted cancer therapies, resistance remains a major challenge that limits the overall clin...

Journal: :Trends in immunology 2015
Seth B Coffelt Karin E de Visser

Conventional anticancer therapies, such as chemotherapy, radiotherapy, and targeted therapy, are designed to kill cancer cells. However, the efficacy of anticancer therapies is not only determined by their direct effects on cancer cells but also by off-target effects within the host immune system. Cytotoxic treatment regimens elicit several changes in immune-related parameters including the com...

2014
Grant D. Stewart Fiach C. O’Mahony Alexander Laird Sukaina Rashid Sarah A. Martin Lel Eory Alexander L.R. Lubbock Jyoti Nanda Marie O’Donnell Alan Mackay Peter Mullen S. Alan McNeill Antony C.P. Riddick Michael Aitchison Daniel Berney Axel Bex Ian M. Overton David J. Harrison Thomas Powles

BACKGROUND There is a lack of biomarkers to predict outcome with targeted therapy in metastatic clear cell renal cancer (mccRCC). This may be because dynamic molecular changes occur with therapy. OBJECTIVE To explore if dynamic, targeted-therapy-driven molecular changes correlate with mccRCC outcome. DESIGN, SETTING, AND PARTICIPANTS Multiple frozen samples from primary tumours were taken f...

2008
Xiaoguang Liu Chao Ma Lufang Zhou

*Author for correspondence: [email protected] Cancer is one leading cause of mortality that is associated with genetic background or environmental toxin [1]. Multiple anti-cancer therapies have been developed and applied clinically such as surgery, chemotherapy, radiotherapy, therapeutic antibody, small molecule, Antibody-Drug Conjugate (ADC), cellular immunotherapy, chemoimmunotherapy, and radioimm...

2006
N. Gupta A. Srivastava

In an ongoing quest to improve the therapeutic arsenal against cancer, a fourth weapon Intas Biotechnology/Oncology, Plot other than surgery, chemotherapy and radiotherapy has emerged, i.e. targeted therapy. No. 423/P/A/GIDC, Sarkhej Bavla Targeted therapy includes, tyrosine kinase receptor inhibitors (small molecule inhibitors Highway, Moraiya, Tal: Sanand, Ahmedabad-382 210. India like imatin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید